GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (OTCPK:BMXMF) » Definitions » Net Policyholder Benefits/Claims

BioMerieux (BioMerieux) Net Policyholder Benefits/Claims


View and export this data going back to 2009. Start your Free Trial

What is BioMerieux Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


BioMerieux (BioMerieux) Business Description

Traded in Other Exchanges
Address
Marcy l’Etoile, Lyon, FRA, 69280
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.